Login / Signup
mTOR inhibitors are the first-choice therapy for renal angiomyolipomas secondary to tuberous sclerosis.
Aline Grosskopf Monich
Mariana Faucz Munhoz da Cunha
Fellype de Carvalho Barreto
Published in:
Jornal brasileiro de nefrologia (2023)
Keyphrases
</>
cell proliferation
decision making